http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112599237-B

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2030-8813
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N30-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N27-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N30-8696
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H50-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H50-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N21-31
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H10-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N30-8634
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N30-88
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N30-72
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N24-082
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N27-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N30-72
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N30-88
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H10-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N30-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N24-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N21-31
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N30-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H50-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H50-20
filingDate 2020-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2022-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2022-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-112599237-B
titleOfInvention Biomarker and application thereof in cerebral infarction diagnosis
abstract The invention discloses a biomarker and application thereof in cerebral infarction diagnosis, and particularly discloses a biomarker PC (14:0/18:2(9Z,12Z)), wherein the level of cerebral infarction of the biomarker PC (14:0/18:2(9Z,12Z)) is reduced compared with that of a healthy control, and the biomarker PC (14:0/18:2(9Z,12Z)) is used as a detection variable, so that the biomarker has higher efficiency of distinguishing the cerebral infarction from the healthy control.
priorityDate 2020-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020146263-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105441550-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534865
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID9606
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4091
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419501648
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID133017
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419497074
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID9606
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506124
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100009450
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID1471
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID109632944
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID396497
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4075
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2802
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450805708
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID281102
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21864698
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID25307
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID13010

Total number of triples: 51.